Cargando…
Safety of poly-L-lactic acid (New-Fill(®)) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients
BACKGROUND: Facial lipoatrophy is a frequently reported condition associated with use of antiretroviral (ARV) drugs. Poly-L-lactic acid (PLLA) acid has been used to correct facial lipoatrophy in people with HIV since 2004 both in Europe and the United States. The objective of this study was to estab...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160543/ https://www.ncbi.nlm.nih.gov/pubmed/25178390 http://dx.doi.org/10.1186/1471-2334-14-474 |